Open: OPTImizing CArdiac REhabilitation by REfining Sleep and STress (OPTICARE-RESST)

Trial Status Open
Overall study start date 24-08-2028
Overall study end date
Country The Netherlands
Trial Number NCT06505109
Trial URL https://clinicaltrials.gov/study/NCT06505109
Summary The primary objective of this project is to investigate the effectiveness and costs of integrating a behavioural program targeting sleep and stress (the RESST intervention) into cardiac rehabilitation (CR). In addition, the investigators will also study whether parameters regarding diversity (e.g., sex, ethnicity, socioeconomic position) are associated with intervention effectiveness. Furthermore, the investigators aim to explore the (bidirectional) relation between sleep and stress on the one hand, and other lifestyle components and health outcomes on the other hand.
Study Design Randomized controlled trial
Study Setting(s)
Study Acronym
Study Hypotheses Adding a behavioural intervention will improve sleep and perceived stress (primary outcomes), along with positive outcomes on biomarkers of chronic stress, QoL, cardiometabolic risk factors, physical fitness, lifestyle components, and psychosocial well-being.
Condition (Cardio)vascular disease
Intervention Subjects randomized to the RESST intervention will receive on top of standard rehabilitation a behavioural group intervention focussing on improving sleep and stress. This intervention will consist of 5 till 6 meetings of 90 till 120 minutes in the local rehabilitation centre during a time period of 3 till 4 months.
Primary Outcome Measure Information regarding sleep and stress
Secondary Outcome Measure Cortisol level Cortisone level Weight Height Body Mass Index (BMI) Blood pressure Smoking behaviour Smoking behaviour Muscle strength Physical activity Sedentary behaviour Alcohol use Health related quality of life Health related quality of life Fatigue Daytime sleepiness Anxiety and depression Participation in society Estimated Cardiorespiratory fitness Presence of restless leg syndrome Presence of insomnia The risk of the presence of obstructive sleep apnoea Costs incurred by the patients Productivity costs Perceived sleep Diet Momentary fatigue Momentary stress Adherence to the CR treatment and RESST intervention Treatment Satisfaction Sex Age Cardiac diagnosis Educational level Relational status Cardiac risk factors Cardiac history Medication usage Comorbidity Socioeconomic status Origin Employment Drug use Current/previous sleep disorder treatment

Eligibility

Participant Type(s) (Cardio)vascular disease
Age Group Adult (18-64), Senior (65+)
Sex Both
Target Number of Participants 200
Total Final Enrolment
Participant Inclusion Criteria - Age at or above 18 years - Proficient in the Dutch language - Experiencing sleep and/or stress problems as indicated by a high score on the Pittsburgh Sleep Quality Index (PSQI score >5) or Perceived Stress Scale-10 (PSS-10 score >13) - Signed informed consent
Participant Exclusion Criteria - Severe psychiatric, cognitive or physical comorbidity that would impede CR participation - Active treatment for sleep disorders, stress, or other forms of (behavioural) therapy at the start of the study or expected to start within the first 6 months of the study, that could interfere with the RESST intervention. Note: Participants with previously diagnosed sleep disorders are eligible if they still experience sleep or stress problems, unless they fall under the above criteria. Participants who received a prior treatment that is still ongoing but has resulted in a stable sleep and stress condition in the 3 months before the cardiovascular event (e.g., Continuous Positive Airway Pressure (CPAP)) are eligible.